Derma Sciences (DSCI) Prelim. Q4, FY15 Sale Miss Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Derma Sciences (DSCI) Prelim. Q4, FY15 Sale Miss Views

Oppenheimer Cuts Price Target Following Derma Sciences' (DSCI) 4Q Preliminary Results

January 8, 2016 9:23 AM EST

Oppenheimer maintained an Outperform rating on Derma Sciences (NASDAQ: DSCI), and cut the price target to $7.00 (from $8.00), following the company's preliminary 4Q15 results. 4Q sales were ~$1.9M below on Advanced Wound Care (AWC) and ~$1.5M below on Traditional Wound Care (TWC).

Analyst Steven Lichtman... More

Canaccord Genuity Downgrades Derma Sciences (DSCI) to Hold

January 7, 2016 9:43 AM EST

Canaccord Genuity downgraded Derma Sciences (NASDAQ: DSCI) from Buy to Hold.

For an analyst ratings summary and ratings history on Derma Sciences click here. For more ratings news on Derma Sciences click here.

Shares of Derma Sciences closed at $4.32 yesterday.

... More